W. Mark Watson - Aug 4, 2022 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
Director
Signature
/s/ Edward Berg, Attorney-in-Fact for W. Mark Watson
Stock symbol
VXRT
Transactions as of
Aug 4, 2022
Transactions value $
$0
Form type
4
Date filed
8/8/2022, 06:39 PM
Previous filing
Jun 14, 2022
Next filing
Dec 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VXRT Common Stock Award $0 +14.8K $0.00 14.8K Aug 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +88.4K $0.00 88.4K Aug 4, 2022 Common Stock 88.4K $3.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of shares upon vesting of restricted stock units. One third of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the third anniversary of the grant date.
F2 The shares subject to this option shall vest annually over three years from the vesting commencement date of August 4, 2022, the date of the grantee's appointment as a director of Vaxart, Inc.